Micah T. McClain, Ph.D. - Publications

2002 University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States 
Immunology, Pathology

35 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Jog NR, McClain MT, Heinlen LD, Gross T, Towner R, Guthridge JM, Axtell RC, Pardo G, Harley JB, James JA. Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine model. Journal of Autoimmunity. 102332. PMID 31515129 DOI: 10.1016/j.jaut.2019.102332  0.64
2016 Tsalik EL, Henao R, Nichols M, Burke T, Ko ER, McClain MT, Hudson LL, Mazur A, Freeman DH, Veldman T, Langley RJ, Quackenbush EB, Glickman SW, Cairns CB, Jaehne AK, et al. Host gene expression classifiers diagnose acute respiratory illness etiology. Science Translational Medicine. 8: 322ra11. PMID 26791949 DOI: 10.1126/Scitranslmed.Aad6873  0.64
2016 Yang WE, Suchindran S, Nicholson BP, McClain MT, Burke T, Ginsburg GS, Harro CD, Chakraborty S, Sack DA, Woods CW, Tsalik EL. Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in Humans. The Journal of Infectious Diseases. PMID 26787651 DOI: 10.1093/Infdis/Jiv593  0.64
2016 Berry SM, Petzold EA, Dull P, Thielman NM, Cunningham CK, Corey GR, McClain MT, Hoover DL, Russell J, Griffiss JM, Woods CW. A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response. Clinical Trials (London, England). PMID 26768569 DOI: 10.1177/1740774515621721  0.64
2015 McClain MT, Henao R, Williams J, Nicholson B, Veldman T, Hudson L, Tsalik EL, Lambkin-Williams R, Gilbert A, Mann A, Ginsburg GS, Woods CW. Differential evolution of peripheral cytokine levels in symptomatic and asymptomatic responses to experimental influenza virus challenge. Clinical and Experimental Immunology. PMID 26506932 DOI: 10.1111/Cei.12736  0.64
2015 Ko ER, Yang WE, McClain MT, Woods CW, Ginsburg GS, Tsalik EL. What was old is new again: using the host response to diagnose infectious disease. Expert Review of Molecular Diagnostics. 1-16. PMID 26145249 DOI: 10.1586/14737159.2015.1059278  0.64
2015 Tsalik EL, McClain M, Zaas AK. Moving toward prime time: host signatures for diagnosis of respiratory infections. The Journal of Infectious Diseases. 212: 173-5. PMID 25637349 DOI: 10.1093/Infdis/Jiv032  0.64
2014 Tsalik EL, Langley RJ, Dinwiddie DL, Miller NA, Yoo B, van Velkinburgh JC, Smith LD, Thiffault I, Jaehne AK, Valente AM, Henao R, Yuan X, Glickman SW, Rice BJ, McClain MT, et al. An integrated transcriptome and expressed variant analysis of sepsis survival and death. Genome Medicine. 6: 111. PMID 25538794 DOI: 10.1186/S13073-014-0111-5  0.64
2013 McClain MT, Park LP, Nicholson B, Veldman T, Zaas AK, Turner R, Lambkin-Williams R, Gilbert AS, Ginsburg GS, Woods CW. Longitudinal analysis of leukocyte differentials in peripheral blood of patients with acute respiratory viral infections. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 58: 689-95. PMID 24140015 DOI: 10.1016/j.jcv.2013.09.015  0.64
2013 Zaas AK, Burke T, Chen M, McClain M, Nicholson B, Veldman T, Tsalik EL, Fowler V, Rivers EP, Otero R, Kingsmore SF, Voora D, Lucas J, Hero AO, Carin L, et al. A host-based RT-PCR gene expression signature to identify acute respiratory viral infection. Science Translational Medicine. 5: 203ra126. PMID 24048524 DOI: 10.1126/Scitranslmed.3006280  0.64
2013 Bagga B, Woods CW, Veldman TH, Gilbert A, Mann A, Balaratnam G, Lambkin-Williams R, Oxford JS, McClain MT, Wilkinson T, Nicholson BP, Ginsburg GS, Devincenzo JP. Comparing influenza and RSV viral and disease dynamics in experimentally infected adults predicts clinical effectiveness of RSV antivirals. Antiviral Therapy. 18: 785-91. PMID 23714753 DOI: 10.3851/IMP2629  0.64
2013 Woods CW, McClain MT, Chen M, Zaas AK, Nicholson BP, Varkey J, Veldman T, Kingsmore SF, Huang Y, Lambkin-Williams R, Gilbert AG, Hero AO, Ramsburg E, Glickman S, Lucas JE, et al. A host transcriptional signature for presymptomatic detection of infection in humans exposed to influenza H1N1 or H3N2. Plos One. 8: e52198. PMID 23326326 DOI: 10.1371/Journal.Pone.0052198  0.64
2011 Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, McClain MT, Denny TN, Chen X, Munshaw S, Marshall DJ, Whitesides JF, Drinker MS, Amos JD, Gurley TC, Eudailey JA, et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. Plos One. 6: e25797. PMID 22039424 DOI: 10.1371/Journal.Pone.0025797  0.64
2011 Huang Y, Zaas AK, Rao A, Dobigeon N, Woolf PJ, Veldman T, Øien NC, McClain MT, Varkey JB, Nicholson B, Carin L, Kingsmore S, Woods CW, Ginsburg GS, Hero AO. Temporal dynamics of host molecular responses differentiate symptomatic and asymptomatic influenza a infection. Plos Genetics. 7: e1002234. PMID 21901105 DOI: 10.1371/Journal.Pgen.1002234  0.64
2010 Heinlen LD, Ritterhouse LL, McClain MT, Keith MP, Neas BR, Harley JB, James JA. Ribosomal P autoantibodies are present before SLE onset and are directed against non-C-terminal peptides. Journal of Molecular Medicine (Berlin, Germany). 88: 719-27. PMID 20396862 DOI: 10.1007/s00109-010-0618-1  0.64
2010 Heinlen LD, McClain MT, Ritterhouse LL, Bruner BF, Edgerton CC, Keith MP, James JA, Harley JB. 60 kD Ro and nRNP A frequently initiate human lupus autoimmunity. Plos One. 5: e9599. PMID 20224770 DOI: 10.1371/journal.pone.0009599  0.64
2007 James JA, Kim-Howard XR, Bruner BF, Jonsson MK, McClain MT, Arbuckle MR, Walker C, Dennis GJ, Merrill JT, Harley JB. Hydroxychloroquine sulfate treatment is associated with later onset of systemic lupus erythematosus. Lupus. 16: 401-9. PMID 17664230 DOI: 10.1177/0961203307078579  0.64
2007 Heinlen LD, McClain MT, Merrill J, Akbarali YW, Edgerton CC, Harley JB, James JA. Clinical criteria for systemic lupus erythematosus precede diagnosis, and associated autoantibodies are present before clinical symptoms. Arthritis and Rheumatism. 56: 2344-51. PMID 17599763 DOI: 10.1002/art.22665  0.64
2006 McClain MT, Poole BD, Bruner BF, Kaufman KM, Harley JB, James JA. An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus. Arthritis and Rheumatism. 54: 360-8. PMID 16385527 DOI: 10.1002/art.21682  0.64
2005 Scofield RH, Kurien BT, Ganick S, McClain MT, Pye Q, James JA, Schneider RI, Broyles RH, Bachmann M, Hensley K. Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading. Free Radical Biology & Medicine. 38: 719-28. PMID 15721982 DOI: 10.1016/j.freeradbiomed.2004.11.001  0.64
2005 McClain MT, Heinlen LD, Dennis GJ, Roebuck J, Harley JB, James JA. Early events in lupus humoral autoimmunity suggest initiation through molecular mimicry. Nature Medicine. 11: 85-9. PMID 15619631 DOI: 10.1038/nm1167  0.64
2004 McClain MT, Arbuckle MR, Heinlen LD, Dennis GJ, Roebuck J, Rubertone MV, Harley JB, James JA. The prevalence, onset, and clinical significance of antiphospholipid antibodies prior to diagnosis of systemic lupus erythematosus. Arthritis and Rheumatism. 50: 1226-32. PMID 15077305 DOI: 10.1002/art.20120  0.64
2004 McClain MT, Lutz CS, Kaufman KM, Faig OZ, Gross TF, James JA. Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response. Proceedings of the National Academy of Sciences of the United States of America. 101: 3551-6. PMID 14988508 DOI: 10.1073/pnas.0306267101  0.64
2004 Kelleher P, James JA, McClain MT, Arbuckle MR, Harley JB. Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus [3] (multiple letters) New England Journal of Medicine. 350: 305. PMID 14724314 DOI: 10.1056/NEJM200401153500320  0.64
2003 Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. The New England Journal of Medicine. 349: 1526-33. PMID 14561795 DOI: 10.1056/NEJMoa021933  0.64
2003 Heinlen LD, McClain MT, Kim X, Quintero DR, James JA, Harley JB, Scofield RH. Anti-Ro and anti-nRNP response in unaffected family members of SLE patients. Lupus. 12: 335-7. PMID 12729062 DOI: 10.1191/0961203303lu377xx  0.64
2003 McClain MT, Rapp EC, Harley JB, James JA. Infectious mononucleosis patients temporarily recognize a unique, cross-reactive epitope of Epstein-Barr virus nuclear antigen-1. Journal of Medical Virology. 70: 253-7. PMID 12696112 DOI: 10.1002/jmv.10385  0.64
2003 Arbuckle MR, James JA, Dennis GJ, Rubertone MV, McClain MT, Kim XR, Harley JB. Rapid clinical progression to diagnosis among African-American men with systemic lupus erythematosus. Lupus. 12: 99-106. PMID 12630753 DOI: 10.1191/0961203303lu334oa  0.64
2002 McClain MT, Scofield RH, Kurien BT, Gross TF, James JA. Selective small antigenic structures are capable of inducing widespread autoimmunity which closely mimics the humoral fine specificity of human SLE. Scandinavian Journal of Immunology. 56: 399-407. PMID 12234261 DOI: 10.1046/j.1365-3083.2002.01141.x  0.64
2002 Lutz CS, McClain MT, Harley JB, James JA. Anti-U1A monoclonal antibodies recognize unique epitope targets of U1A which are involved in the binding of U1 RNA. Journal of Molecular Recognition : Jmr. 15: 163-70. PMID 12203842 DOI: 10.1002/jmr.569  0.64
2002 McClain MT, Ramsland PA, Kaufman KM, James JA. Anti-sm autoantibodies in systemic lupus target highly basic surface structures of complexed spliceosomal autoantigens. Journal of Immunology (Baltimore, Md. : 1950). 168: 2054-62. PMID 11823543  0.64
2001 McClain MT, Harley JB, James JA. The role of Epstein-Barr virus in systemic lupus erythematosus. Frontiers in Bioscience : a Journal and Virtual Library. 6: E137-47. PMID 11578968  0.64
2001 Kaufman KM, Kirby MY, McClain MT, Harley JB, James JA. Lupus autoantibodies recognize the product of an alternative open reading frame of SmB/B'. Biochemical and Biophysical Research Communications. 285: 1206-12. PMID 11478783 DOI: 10.1006/bbrc.2001.5302  0.64
1999 James JA, McClain MT, Koelsch G, Williams DG, Harley JB. Side-chain specificities and molecular modelling of peptide determinants for two anti-Sm B/B' autoantibodies. Journal of Autoimmunity. 12: 43-9. PMID 10028021 DOI: 10.1006/jaut.1998.0252  0.64
1998 McClain MT, Kaufman KM, Koelsch G, Harley JB, James JA. Identification and analysis of peptide determinants of murine monoclonal anti-Sm B/B' autoantibodies Faseb Journal. 12.  0.64
Show low-probability matches.